See every side of every news story
Get Started
SubscribeLogin
Published • loading... • Updated

EU Medicines Agency Reverses Course on Eli Lilly's Alzheimer Drug

Summary by EURACTIV
The EU's medicines regulator said it would approve the treatment for a limited group of patients, citing concerns over side effects

3 Articles

Svenska DagbladetSvenska Dagbladet
Lean Right

Turnaround Regarding New Alzheimer's Drug

The European Medicines Agency (EMA) is changing its mind and is now recommending that the EU Commission approve the drug Kisunla for early Alzheimer's disease, reports Läkartidningen.

·Stockholm, Sweden
Read Full Article
EURACTIVEURACTIV
Lean Left

EU medicines agency reverses course on Eli Lilly's Alzheimer drug

The EU's medicines regulator said it would approve the treatment for a limited group of patients, citing concerns over side effects

·Brussels, Belgium
Read Full Article
endpoints.newsendpoints.news

CHMP backs Lilly’s Alzheimer’s drug in certain patients, Gilead’s twice-yearly HIV prevention shot, among others

CHMP endorses 13 new medicines including Lilly's Alzheimer's drug Kisunla and Gilead's HIV preventive lenacapavir, while rejecting three drugs including Sarepta's Elevidys.

Read Full Article
Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/yearSubscribe

Bias Distribution

  • 50% of the sources lean Left, 50% of the sources lean Right
50% Right

Factuality 

To view factuality data please Upgrade to Premium

Ownership

To view ownership data please Upgrade to Vantage

endpoints.news broke the news in on Friday, July 25, 2025.
Sources are mostly out of (0)

Similar News Topics

Alzheimer's Disease icon

Alzheimer's Disease

HIV icon

HIV

Alzheimer's Disease icon

Alzheimer's Disease

Eli Lilly icon

Eli Lilly

European Union icon

European Union

Medical icon

Medical

You have read 1 out of your 5 free daily articles.

Join millions of well-informed readers who use Ground to compare coverage, check their news blindspots, and challenge their worldview.

News
For You
SearchBlindspotLocal